Advertisement

Hyaluronic Acid Filler for the Malar Area

  • Ricardo Limongi FernandesEmail author
Living reference work entry

Latest version View entry history

First Online:
Part of the Clinical Approaches and Procedures in Cosmetic Dermatology book series (CAPCD)

Abstract

Until the 1990s, the concept of rejuvenation was reduced essentially to the absence of lines and folds. During the last decade, there have been significant advances in the technology embedded in hyaluronic acid (HA) products, as well as a refinement of application techniques that, together, also permitted the HA to become a gold standard as a volumizing agent. The main modification in the facial aesthetic treatment has been the exchange of the two-dimensional focus, to the appreciation of the three-dimensional concept, which also recognizes volumetric losses due to bone resorption, gingival retraction, and redistribution of facial fat as signs of aging. The concept is based on balance and facial harmony, respecting patients’ gender, ethnicity, and objectives, and allows for more natural results without “frozen” or distorted expressions. The aim of this chapter is to show a practical view of the use of HA for volumizing the malar region (important anatomical concepts, areas of risk, kinds of fillers and rheological concepts, techniques with needle and cannula, adverse events and treatment of complications), with literature-based information and tips from the author. The midfacial area (malar area) is the starting point for the three-dimensional approach in rejuvenation treatment. The use of HA in this area is effective and safe.

Keywords

Hyaluronic acid Malar area Filler Rejuvenation Cheek Injectable Complication Zygomatic arch Fat compartments Midfacial 
This is a preview of subscription content, log in to check access.

References

  1. Alijotas-Reig J, et al. Are bacterial growth and/or chemotaxis increased by filler injections? Implications for the pathogenesis and treatment of filler-related granulomas. Dermatology. 2010;221:356–64.PubMedCrossRefGoogle Scholar
  2. Andre P. Evaluation of the safety of a non-animal stabilized hyaluronic acid (NASHA – Q-Medical, Sweden) in European countries: a retrospective study from 1997 to 2001. JEADV. 2004;18:422–5.PubMedGoogle Scholar
  3. Bergeret-Galley C. Comparison of resorbable soft tissue fillers. Aesthet Surg J. 2004;24(1):33–46.PubMedCrossRefGoogle Scholar
  4. Cassuto D. Managing filler complications. Merge on line. 2010. www.mergeonline.com.
  5. Cohen JL. Understanding, avoiding, and managing dermal filler complications. Dermatol Surg. 2008;34:S92–9.PubMedGoogle Scholar
  6. Cohen JL, et al. Systematic review of clinical trials of small and large-gel-particle hyaluronic acid injectable fillers for aesthetic soft tissue augmentation. Dermatol Surg. 2013;39(2):205–31.PubMedCrossRefGoogle Scholar
  7. Delorenzi C, et al. A multicenter study of the efficacy and safety of subcutaneous nonanimal stabilized hyaluronic acid in Aesthetics facial contouring: interim report. Dermatol Surg. 2006;32(2):205–11.PubMedGoogle Scholar
  8. Derek H, Jared J. Safety and efficacy of volumizing hyaluronic acid filler for treatment of HIV-associated facial lipoatrophy. JAMA Dermatol. 2016;  https://doi.org/10.1001/jamadermatol.2016.3827. Published online 2 Nov 2016.CrossRefGoogle Scholar
  9. Duranti F, et al. Injectable hyaluronic acid gel for soft tissue augmentation. A clinical and histological study. Dermatol Surg. 1998;24(12):1317–25.PubMedCrossRefGoogle Scholar
  10. Fernandes RL. Conceito tridimensional: nova tendência no tratamento estético facial. Rev Bras Med. 2011;11(4):126–8.Google Scholar
  11. Fernandez-Acenero MJ, et al. Granulomatous foreign body reaction against hyaluronic acid: report of a case after lip augmentation. Dermatol Surg. 2003;29:1225–6.PubMedCrossRefGoogle Scholar
  12. Friedman PM, et al. Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft-tissue augmentation. Dermatol Surg. 2002;28(6):491–4.PubMedGoogle Scholar
  13. Gassia V, et al. Global facial rejuvenation: perioral, nose, and ear. J Cosmet Dermatol. 2013;12(2):123–36.PubMedCrossRefGoogle Scholar
  14. Honig JF, et al. Severe granulomatous allergic tissue reaction after hyaluronic acid injection in the treatment of facial lines and its surgical correction. J Cranofacial Surg. 2003;14(2):197–200.CrossRefGoogle Scholar
  15. Lemperle G, et al. Avoiding and treating dermal filler complications. Cosmetic. 2014;118:3S.PubMedCrossRefGoogle Scholar
  16. Lowe NJ, et al. Hyaluronic acid skin fillers: adverse reactions and skin testing. J Am Acad Dermatol. 2001;45(6):930–3.PubMedCrossRefGoogle Scholar
  17. Lowe NJ, et al. Adverse reactions to dermal fillers: review. Dermatol Surg. 2005;31(11 Pt 2):1616–25.PubMedGoogle Scholar
  18. Lupton JR, Alster TS. Cutaneous hypersensitivity reaction to injectable hyaluronic acid gel. Dermatol Surg. 2000;26(2):135–7.PubMedCrossRefGoogle Scholar
  19. Matarasso SL, Carruthers JD, Jewell ML, Restylane Consensus Group. Consensus recommendations for soft-tissue augmentation with nonanimal stabilized hyaluronic acid (Restylane®) (NASHA). Plast Reconst Surg. 2006;117:3S.PubMedCrossRefGoogle Scholar
  20. Micheels P. Human anti hyaluronic acid antibodies: is it possible? Dermatol Surg. 2001;27:185–91.PubMedGoogle Scholar
  21. Narins RS, et al. A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg. 2003;29:588–95.PubMedGoogle Scholar
  22. Olenius M. The first clinical study using a new biodegradable implant for the treatment of lips, wrinkles and folds. Aesthet Plast Surg. 1998;22:97–101.CrossRefGoogle Scholar
  23. Pons-Guirard A. Actualisation des effets secondaires des produits de comblement de rides. Nouv Dermatol. 2003;22:205–10.Google Scholar
  24. Raulin C, et al. Exudative granulomatous reaction to hyaluronic acid (Hylaform®). Contact Dermatitis. 2000;43:178–9.PubMedGoogle Scholar
  25. Rohrich R, Pessa J. The fat compartments of the face: anatomy and clinical implications for cosmetic surgery. Plast Reconstr Surg. 2008;119:2219–27.CrossRefGoogle Scholar
  26. Schanz S, et al. Arterial embolization caused by injection of hyaluronic acid (Restylane®). Br J Dermatol. 2002;146:928–9.PubMedCrossRefGoogle Scholar
  27. Shafir R, et al. Long-term complications of facial injections with Restylane (injectable hyaluronic acid). Plast Reconstr Surg. 2000;106(5):1215–6.PubMedCrossRefGoogle Scholar
  28. Sherman RN. Avoiding dermal filler complications. Clin Dermatol. 2009;27:S23–32.CrossRefGoogle Scholar
  29. US- FDA. Executive summary dermal fillers devices dated of 18th November 2008.Google Scholar
  30. Vleggaar D, Fitzgerald R. Dermatological implications of skeletal aging: a focus on supraperiostal volumization for perioral rejuvenation. J Drugs Dermatol. 2008;7(3):209–20.PubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.DermatologyInstituto de Cirurgia Plástica Santa CruzSão PauloBrazil

Personalised recommendations

Cite entry